N-(2-Butyn-1-yl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycine integrates a terminal alkyne with an Fmoc-protected backbone, enabling bioorthogonal reactivity. The residue aids in click-chemistry conjugation and distance-controlled labeling. Researchers employ it to study sterically constrained geometries and backbone flexibility. Its design suits modular synthetic strategies.
![N-(2-Butyn-1-yl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycine(CAS 2639419-13-7)](https://img.creative-peptides.com/structure/2639419-13-72d.png)
CAT No: R2180
CAS No:2639419-13-7
Synonyms/Alias:2639419-13-7;N-(2-Butyn-1-yl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycine;EN300-28228642;2-[(but-2-yn-1-yl)({[(9H-fluoren-9-yl)methoxy]carbonyl})amino]acetic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More